Clippings

Tatum Anderson

Journalist, writer and editor

I have written science, technology, international development, business and travel articles for almost 20 years. More recently my focus has moved to global health.

I've written for newspapers, science, business and medical publications from The Lancet to the WHO Bulletin, The Economist, British Medical Journal, BBC News, Guardian, Intellectual Property Watch and Nature.

I am available for freelance commissions and will write features, white papers, supplements, reports and copy for internal magazines and websites.

United Kingdom

Portfolio

the Guardian
Bad medicine: the toxic fakes at the heart of an international criminal racket
Sometimes the vials are filled with dirty water. Occasionally they contain saline and a tiny amount of antibiotic, so as not to infect the site of the vaccination and draw...
Nature
Trip into the unknown
News: Business A plant in Uganda hopes to sell cut-price drugs by taking advantage of exemptions from rules that protect patents. But its operators face major obstacles, as...
The BMJ
The politics of pain
Pain relief is often taken for granted in the Western world, but in about 150 countries the use of morphine is severely restricted. Tatum Anderson investigates how this has come...
BBC News
Africa hails new meningitis vaccine - BBC News
For the people in Niger, Mali and Burkina Faso, a new meningitis vaccine offers hope of an escape from one of the world's deadliest, most disabling and infectious diseases. So...
International Hospitals & Medical Travel
Journeying for the wonder drug
HepC medical tourism. What you do get when you cross a millionaire Argentinian football star, Egyptian pyramids, a government department and a pharmaceutical company? The launch...
Bulletin of the World Health Organization
Providing family planning services to women in Africa
article published in September 2017
International Hospitals and Medical Travel
Israel's proposed medical tourism legislation
Tatum Anderson investigates how a new bill from the Ministries of Health and Tourism seeks to improve treatment for Israeli patients It's not just the world-famous therapeutic...
Intellectual Property Watch
Access To Generic Reproductive Health Supplies Decades Behind Medicines? - Intellectual Property...
Despite a massive worldwide push to improve access to contraceptives, generic manufacturers say they're not yet getting a good share of the pie. The use of family-planning...
Intellectual Property Watch
Enter The African Medicines Agency, Continent's First Super-Regulator? - Intellectual Property Watch
by for Intellectual Property Watch An African medicines agency, the continent's first super-regulator, could be approved as soon as next year. Available only for IP-Watch...
Intellectual Property Watch
Better Data On Fake Drugs Needed To Fight The Scourge - Intellectual Property Watch
by for Intellectual Property Watch The problem of fake medicines is a big one. But precisely how big? The problem is, when reporting numbers, news stories, reports and...
Bulletin of the World Health Organization
Communicating science-based messages on vaccines
The Lancet
Countries mull over incentives for developing antibiotics
Governments are considering which financial incentives will be the best to boost research and development for much needed new antibiotic drugs. Tatum Anderson reports.
WHO Bulletin
Curbing prescription opioid dependency
Intellectual Property Watch
The Deepening Debate Over Vaccines And Antimicrobial Resistance Involves IP - Intellectual...
by for Intellectual Property Watch With the looming threat of antimicrobial resistance (AMR), there is growing pressure to use vaccines because they obviate the need to...
Intellectual Property Watch
Shortage Of Affordable Insulin: Should WHO Extend Prequalification To Biosimilars? - Intellectual...
The WHO last week announced plans to explore options for prequalifying insulin, a process that already assesses the quality, safety and efficacy of medicinal products, such as...
Intellectual Property Watch
06/05/2017
Polypills: Are Miracle Treatments Being Overlooked? - Intellectual Property Watch
Cardiovascular diseases (CVD), a group of conditions that can result in heart attacks and strokes, is the world's number one killer, accounting for one-third of deaths...
The Lancet
12/09/2016
Doctors lobby for better chronic pain management
Several campaigns and initiatives are underway in Europe and the USA by doctors hoping to improve services and care for patients with chronic pain. Tatum Anderson reports.
International Hospitals and Medical Tourism
Beyond the horizon A look into centres of medical excellence opening ‘outposts’ in different...
A look into centres of medical excellence opening ‘outposts’ in different countries
The Lancet
Can open-source drug development deliver?
Open-source drug development involves open data sharing, collaboration, and results sharing. The aim is to produce new drugs for neglected diseases. But can it work? Tatum...
Ihmt
A question of transparency
13 October 2016 Tatum Anderson looks at global efforts to enhance hospital pricing transparency In March this year, a group of 11 organisations - including one that represents...
Intellectual Property Watch
Indian Company Moves To Provide Affordable Insulin Biosimilar In Europe As Patents Rise -...
by for Intellectual Property Watch Bangalore-based Biocon may become the first Indian company to offer a biosimilar insulin in Europe. And the patent and pricing story is...
Intellectual Property Watch
10/12/2016
Paediatric Cancer Drug Being Developed Entirely In The Open - Intellectual Property Watch
The term "Open" in science is all the rage these days. The Medicines for Malaria Venture (MMV) has posted a Malaria Box, containing over 400 compounds that might be effective...
Intellectual Property Watch
EU Eyes Revamp Of Policy To Speed Drug Approvals In Developing Countries - Intellectual Property...
Article 58, a process introduced by the European Commission to help speed up the time low and middle-income countries take to approve new drugs, could be in for a massive...
All Copyrights Belong To Their Respective Owners